Latest News
17-Mar-2023 After Notices, e-Pharmacies Look to Make aCase to Govt
14-Mar-2023 TPG Capital Looking to Exit Sai Life with a $500-m Cheque
24-Feb-2023 J&J Implants: Decision on Compensation Likely in Mar
23-Feb-2023 Manufacturing Plant
22-Feb-2023 Essential Drugs List to Soon Include Commonly-used Hygiene Products
  more...
Latest Reports
Mar-23 Risk-Reward Favourable - Nirmal Bang  
Jan-23 Domestic formulations expected to support growth... - ICICI direct.com  
Jan-23 Healthy growth in Dec22 volumes slow down - Anand Rathi  
Dec-22 USFDA inspections on a spree - Anand Rathi  
Dec-22 M&A valuations a poser for inorganic growth plans - Nirmal Bang  
  more...

Quarterly Summary December-2022
Desc Current Previous Per.Chg
Sales 54504.4 50424.7 8.1
Otherincome 1497.3 1613.0 -7.2
Expense 44810.7 40595.3 10.4
RawMaterial 18796.1 17983.2 4.5
StaffCost 8137.9 7449.3 9.2
ExciseDuty 44.3 71.3 -37.9
OtherExp 13420.8 11718.8 14.5
Interest 963.4 614.5 56.8
GrossProfit 10987.3 11201.0 -1.9
Depreciation 2628.2 2392.6 9.8
Tax 2136.1 1231.8 73.4
NetProfit 6334.8 7571.2 -16.3
Total.Comp 177 -- --
Source: ETIG Database

Sectoral Companies As on 27 Mar 2023
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 236079.12
Divi's Lab 75090.50
Dr.Reddy's 74702.54
Cipla 71791.96
Torrent Phar 51950.54
Zydus Life 49373.05
Abbott (I) 45533.65
Alkem Labora 38639.76
Lupin 29985.75
Aurobindo Ph 29936.56
Biocon 24780.38
Syngene Intl 23068.17
GlaxoSmith.P 21516.76
  click here for the complete list